Prostate Cancer

Prostate Cancer Linked to Heavy Alcohol Intake

February 03, 2012

SAN FRANCISCO—Heavy ethanol intake is associated with an increased risk of prostate cancer (PCa) among low-risk men with at least one prior negative prostate biopsy, investigators reported here at the annual Genitourinary Cancers Symposium. It also is associated with an elevated risk for high-grade PCa.
 

PSA Testing Rates Unchanged for Elderly Men Despite Task Force Guidelines

February 03, 2012

SAN FRANCISCO—PSA testing rates for men aged 75 years and older did not decline despite a 2008 U.S. Preventive Services Task Force (USPSTF) recommendation against PSA screening for men in this age group, according to study findings presented at the annual Genitourinary Cancers Symposium.
 

Prostate Cancer Patients Far More Likely to Die from Other Causes

February 03, 2012

SAN FRANCISCO—Elderly men who receive definitive local treatment for prostate cancer (PCa) are much more likely to die from causes other than their cancer, a finding that could inform doctor-patient discussions about treatment for localized PCa, investigators reported here at the annual Genitourinary Cancers Symposium.
 

Many Metastatic Prostate Cancers Go Untreated

February 03, 2012

SAN FRANCISCO—Many patients with metastatic prostate cancer (PCa) never receive anticancer treatment, and older age, lower income, and lack of private health insurance may be among the reasons, according to data presented here at the annual Genitourinary Cancers Symposium.
 

Novel Drug Prolongs Survival in Men with Advanced Prostate Cancer

February 03, 2012

SAN FRANCISCO—A novel medication may provide a new standard of care for the treatment of patients with castration-resistant prostate cancer (CRPC) and bone metastases, researchers reported here at the annual Genitourinary Cancers Symposium.
 

Obesity Raises Prostate Cancer Risk in All Races, Ethnicities

February 03, 2012

A new study suggests that obesity is associated with higher rates of prostate cancer screening across all races/ethnicities.
 

Herbal Product May Be Useful for Recurrent Prostate Cancer

February 02, 2012

SAN FRANCISCO—A combination herbal supplement may benefit men with recurrent prostate cancer (PCa), according to a findings presented here at the annual Genitourinary Cancers Symposium.
 

First PSA Results Predict Long-Term Prostate Cancer Risk

February 02, 2012

SAN FRANCISCO—PSA levels at the first date of testing may predict a man's long-term risk of prostate cancer and mortality in the general population, Danish investigators reported here at the annual Genitourinary Cancers Symposium.
 

Eating Rye Bread in Adolescence May Cut Prostate Cancer Risk

February 02, 2012

SAN FRANCISCO—Greater rye bread consumption in adolescence may be associated with a decreased risk of prostate cancer, especially advanced disease, according to findings presented here at the annual Genitourinary Cancers Symposium.
 

Empiric Antibiotics for Elevated PSA of No Clinical Benefit

February 02, 2012

SAN FRANCISCO—New findings presented here at the annual Genitourinary Cancers Symposium challenge the widespread practice of placing patients on an empiric course of antibiotics for a newly elevated PSA levels.
 

Proton Therapy No Better than IMRT for Prostate Cancer

February 02, 2012

SAN FRANCISCO—Proton therapy is no better than intensity modulated radiotherapy (IMRT) as a treatment for localized prostate cancer, and it is associated with greater gastrointestinal toxicities, researchers reported here at the Genitourinary Cancers Symposium.
 

Statins May Lower Prostate Tumor Risk

January 29, 2012

A population-based investigation demonstrated that statin use was associated with substantial protection against death from prostate cancer.
 

Imaging May Spare Nerves in Prostate Cancer Surgery

January 25, 2012

Preoperative MRI led to a change in surgical plan in 27% of robot-assisted prostatectomies
 

Dutasteride Delays Progression of Low-Risk Prostate Cancer

January 25, 2012

For men with low-risk prostate cancer who undergo active surveillance, treatment with dutasteride delays the time to cancer progression, a study found.
 

Prostate Biopsies Rarely Lead to Hospitalization

January 12, 2012

Hospital admissions related to a prostate needle biopsy (PNB) are on the increase, but they occur in less than 1% of men who undergo PNB and are not associated with excess mortality, researchers concluded in an online report in European Urology.
 

Ongoing Prostate Cancer Clinical Trials

Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia

Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer

The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer

Your Practice

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

On The Forefront


On The Forefront

In the past five to 10 years, researchers have developed several techniques to overcome donor incompatibility, including paired donation. The following case illustrates the collaborative efforts between nephrologists and urologists at the Glickman Urological and Kidney Institute.

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

Renal Cell Carcinoma Tumor

An Update on Robotic-Assisted Partial Nephrectomy

Expert Q&A

The Lowdown on HIFU: An Interview with David Y.T. Chen, MD, FACS

David Y.T. Chen, MD, FACS

Renal & Urology News asked urologic oncologist David Y.T. Chen, MD, FACS of Fox Chase Cancer Center in Philadelphia about his impressions of high-intensity focused ultrasound (HIFU) as an investigator in a trial featuring the treatment.
Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Nutrition Overactive Bladder Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions